Amecath

Cairo, Egypt Founded: 2001 • Age: 25 yrs Acquired By TVM Capital
Catheters for dialysis, urology, and central venous uses are contract-manufactured.

About Amecath

Amecath is a company based in Cairo (Egypt) founded in 2001 by Samy Hamboly, and was acquired by TVM Capital in March 2014. Catheters for dialysis, urology, and central venous uses are contract-manufactured.

Company details

Amecath was founded in 2001 in Cairo, Egypt, and operates as a contract manufacturer in the medical device sector. Specialization is placed on dialysis catheters, urology products such as stents and dilators, central venous lines, sheath introducers, and related accessories like hemodialysis kits. Clients including Terumo are served with production of central line products. Pediatric and adult options are included across product lines.

Key Metrics

Investors in Amecath

Amecath has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include TVM Capital Life Science.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Capital is invested in life science innovations for healthcare transformation.
tvm-capital.comMunich, Germany
Premium access

Investor details for Amecath

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Amecath

1 people are tracked at Amecath (1 in leadership).

NameRoleGroup
Samy Hamboly
Co-Founder & ChairmanLeadership
Premium access

Complete people profiles for Amecath

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Amecath

2 dated milestones of Amecath across 13 years, from founding to its latest funding, stage changes and deals.

  1. Founded Amecath is founded.
  2. Exit Acquired by TVM Capital.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Amecath

Amecath was founded in 2001.

Amecath is headquartered in Cairo, Egypt.

Amecath was founded in 2001 in Cairo, Egypt, and operates as a contract manufacturer in the medical device sector. Specialization is placed on dialysis catheters, urology products such as stents and dilators, central venous lines, sheath introducers, and related accessories like hemodialysis kits. Clients including Terumo are served with production of central line products. Pediatric and adult options are included across product lines.

Amecath has 1 investor. Key investors include TVM Capital Life Science.

Yes. Amecath was acquired by TVM Capital in March 2014.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available